Abolis
PrivateLast Round
Early Funding
Sep 13, 2024
Total Funding Raised
$38.6M
Company Overview
Abolis is a biotechnology company that specializes in bio-synthesis processes to optimize microorganism metabolism for the industrial production of complex molecular entities.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing, Drug Discovery, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abolis Comps
Public and private peers based on sector, stage, and business model.
Abolis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 13, 2024 |
Key People
Founding team and executive leadership
Abolis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ICOS Capital | Early Funding |
| DeepTech & Climate Fonds | Early Funding |
| Liberset | Early Funding |
| Clay Capital | Early Funding |
| Evonik Venture Capital | Early Funding |
| BOLD (Business Opportunities for L'Oréal Development) | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 24, 2025
Partnership valued at €140M as part of IPCEI Med4Cure funding.
Abolis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abolis's valuation, stock price, and market status.
